Sir -A recent short communication from Scandinavia (Bengtsson & Hardell, 1986) draws attention again to the unusual prevalence of hepatocellular cancer in patients with porphyria. Their speculation that point mutations, responsible for the enzymatic defects leading to the various porphyrias could be associated with an oncogene is as interesting as the other theory that porphyrins are carcinogenic. A third possibility should be kept in mind, viz. that the hepatocellular carcinoma produces a heme precursor mimicking some of the biochemical findings characteristic of porphyria. We described such a patient (Pierach et al., 1984) in whom a hepatocellular carcinoma produced large amounts of porphobilinogen. The patient did not suffer from symptoms attributable to any of the known porphyrias. Thus we considered this pseudo-porphyria to be a paraneoplastic phenomenon and not a syndrome.
We think the connection between tumours and heme synthesis is a most interesting and promising one, meriting close observation and investigation.
Yours 
